1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. TISSUE BANKING MARKET BY TISSUE TYPE
5.1. Introduction
5.2. Cornea
5.3. Skin
5.4. Bones
5.5. Heart Valves
5.6. Others
6. TISSUE BANKING MARKET BY STORAGE TYPE
6.1. Introduction
6.2. Cryopreservation
6.3. Deep-Freezing
6.4. Others
7. TISSUE BANKING MARKET BY APPLICATION
7.1. Introduction
7.2. Therapeutic
7.3. Research & Development
7.4. Tissue Engineering
7.5. Others
8. TISSUE BANKING MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.3. Research & Academic Institutes
8.4. Others
9. TISSUE BANKING MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Life Link Tissue Bank
11.2. Alamo Biologics
11.3. ViaCord (Revvity Inc.)
11.4. DCI Donor Services Tissue Bank
11.5. Thermo Fisher Scientific Inc.
11.6. Azenta Life Sciences
11.7. Tecan Group Ltd.
11.8. BioLife Solutions, Inc.
11.9. PHC Corporation
11.10. Rokit Healthcare
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF TABLES
LIST OF FIGURES